The multi award winning Calculus EIS Fund has an upcoming close date of 26 January. Contact the team now on info@cc23.codewithfeeling.com or 020 7493 4940 to secure your investment. Access a diversified portfolio of established companies through the Calculus EIS Fund and benefit from the expertise and experience of the Calculus Capital investment team. Our … Continued
Scancell Holdings PLC, a developer of novel immunotherapies for the treatment of cancer, and Cancer Research UK, the world’s leading cancer charity dedicated to saving lives through research, are pleased to announce that they have entered into a Clinical Development Partnership to develop Scancell’s ImmunoBody® vaccine, SCIB2, for the treatment of patients with solid tumours, … Continued
Calculus Capital CEO John Glencross has been featured in the FT Adviser: Guide to investing in EIS. The guide looked into the drivers behind the increased interest in EIS, how accessible these types of investments are, how to navigate the changes to EIS that came out of the Patient Capital Review and differences between EIS and … Continued
Calculus Capital is delighted to have won the award for Best Generalist EIS at the Investment Week Tax Efficiency Awards 2017 – presented by the BBC’s Joe Lynam. The judges noted that ‘Calculus Capital embodies the spirit of what EIS is all about’. The Investment Week Tax Efficiency Awards 2017-18, recognise the most successful and forward-thinking … Continued
Cornerstone has been featured as one of the ‘Ones to Watch 10’ in the 21st annual Sunday Times Virgin Fast Track 100, published in the Business section of the Sunday Times this weekend (3rd December 2017). The Fast Track Ones to Watch 10 represents the best of the rest of the companies who do not quite … Continued
Following the budget last week, John Glencross, CEO of Calculus Capital hosted a webinar discussing the outcome, specifically the effect on EIS and VCT investing. If you would like to view a replay of the session in full, please click here. [youtube id=”KCAI8p61cDU”] As a reminder, both the Calculus EIS and VCT funds are now … Continued
Edinburgh – 28th November 2017 Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson’s disease. The joint project will see the company develop novel gene promoters that specifically control the expression of … Continued
Calculus portfolio company, Once Upon A Time, has acquired the brand activation and shopper marketing agency Toucan. This is Once Upon a Time’s fifth acquisition, and further supports their strategy to offer independent and fully integrated solutions for clients, this includes media, advertising, digital, shopper marketing and production. Once Upon A Time chief executive Joe … Continued
Calculus CEO John Glencross has been featured in a City AM article discussing the upcoming Autumn Budget and the outcome of the Patient Capital Review. “In the government’s Patient Capital Review earlier this year, concerns were raised that VCTs and EISs – which give investors tax breaks to combat the perceived risk of backing young startups … Continued
Benito’s Hat have opened the doors to their new site in Westgate, Oxford. As part of their objective to bring ‘Mexican street food to the masses’, this is the seventh restaurant to be opened. “Representing Mexican cuisine are the cool lads and lasses of Benito’s Hat. Lit up in neon, and advertising burritos and margaritas, it has … Continued